Your browser doesn't support javascript.
loading
Diacerein Alone and in Combination with Infliximab Suppresses the Combined Proinflammatory Effects of IL-17A, IL-22, Oncostatin M, IL-1A, and TNF-alpha in Keratinocytes: A Potential Therapeutic Option in Psoriasis.
Doo, Caroline; Bao, Lei; Shen, Kui; Yang, Jessica F; Shen, Rachel R; Chan, Lawrence S.
Afiliação
  • Doo C; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Bao L; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Shen K; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Yang JF; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Shen RR; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Chan LS; Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois, USA.
J Interferon Cytokine Res ; 41(8): 302-306, 2021 08.
Article em En | MEDLINE | ID: mdl-34410877

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Queratinócitos / Antraquinonas / Mediadores da Inflamação / Infliximab Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Interferon Cytokine Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Queratinócitos / Antraquinonas / Mediadores da Inflamação / Infliximab Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Interferon Cytokine Res Ano de publicação: 2021 Tipo de documento: Article